The incidence of colitis-associated cancer (CAC) in patients with IBD (e.g., UC and CD) continues to be higher than in the general population, and CAC shows a poorer survival rate, with higher NF-κB expression, than sporadic CRC. Here, NFKB1 is linked to inflammatory bowel disease.